FDA pharmaceutical import alert



    TORONTO, Sept. 8 /CNW/ - Apotex today issued the following statement
concerning an Import Alert issued by the US Food and Drug Administration:

    The Import Alert recently posted by FDA applies to products manufactured
at 2 of Apotex's many facilities. This alert relates to observations made
following routine audits for products destined to the US only. We are actively
working with the FDA to resolve the identified concerns as quickly as
possible, and are optimistic that there will be a prompt resolution.
    "We pride ourselves on being a leading maker of top-quality generic
pharmaceuticals," said Jack Kay, President and COO of Apotex. "Since 1974,
Apotex has produced approximately 200 billion tablets and capsules. These safe
and effective products are sold in over 115 countries."





For further information:

For further information: Elie Betito, Director, Public & Government
Affairs, Apotex Inc., Tel: (416) 401-7366, Cell: (416) 558-5491, Fax: (416)
401-3847, e-mail: ebetito@apotex.com


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890